Sorafenib in First-line Treatment of Advanced B Child Hepatocellular Carcinoma
Stopped lack of enrolment
Conditions
- Advanced Adult Hepatocellular Carcinoma
Interventions
- OTHER: Best Supportive Care
- DRUG: sorafenib
Sponsor
National Cancer Institute, Naples